-
COST-EFFECTIVENESS OF SCREENING AND INTERVENTION STRATEGIES FOR PERINATAL DEPRESSION USING MULTI-STATE MARKOV MODEL IN RURAL CHINA
Mar 18, 2026, 21:38 PM -
IMPACT OF GOLD-GUIDED PHARMACIST-LED PHARMACEUTICAL CARE ON CLINICAL OUTCOMES AND QUALITY OF LIFE IN COPD: A PROSPECTIVE RANDOMIZED TRIAL
Mar 18, 2026, 21:38 PM -
EXAMINING PLAN-LEVEL BID DEVIATIONS IN MEDICARE PART D: EVIDENCE FROM 2016-2025
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF NATIONAL HTA DECISIONS IN ANTINEOPLASTIC, IMMUNOMODULATORY, AND NERVOUS SYSTEM THERAPIES ACROSS FOUR EUROPEAN COUNTRIES
Mar 18, 2026, 21:38 PM -
COMPARISON OF ISCHEMIC STROKE INCIDENCE RATES IN HUNGARY AND EUROPE BASED ON DATA FROM THE GLOBAL BURDEN OF DISEASE STUDY
Mar 18, 2026, 21:38 PM -
GENERATIVE AI IN HEALTH ECONOMIC MODELLING: A TARGETED REVIEW OF EMERGING APPLICATIONS AND METHODOLOGICAL GAPS
Mar 18, 2026, 21:38 PM -
COMPARING CONTINUOUS AND BINARY GROUP-BASED TRAJECTORY MODELS OF MEDICATION ADHERENCE IN CHRONIC HEPATITIS B
Mar 18, 2026, 21:38 PM -
OFF-LABEL USE AND ADHERENCE TO GLP-1S AS ADJUNCT THERAPY IN TYPE 1 DIABETES: A COMPARATIVE ANALYSIS VERSUS METFORMIN
Mar 18, 2026, 21:38 PM -
ALTERNATIVE PAYMENT MODELS IN CARDIOLOGY: A SCOPING REVIEW OF DESIGN FEATURES, QUALITY OUTCOMES, AND COSTS
Mar 18, 2026, 21:38 PM -
RISKY BUSINESS: HOW HEALTH PREFERENCE RESEARCH CAPTURES RISK TOLERANCE
Mar 18, 2026, 21:38 PM -
ANALYSING THE IMPACT OF SHARED DECISION MAKING AMONGST CANCER PATIENTS ON TOTAL MEDICAL EXPENDITURE BY PAYER TYPE AND NUMBER OF EMERGENCY VISITS
Mar 18, 2026, 21:38 PM -
POTENTIAL BENEFITS OF RSV VACCINATION IN COLOMBIAN ADULTS AGED 60 AND OVER: A COST-UTILITY ANALYSIS
Mar 18, 2026, 21:38 PM -
REAL-WORLD COMPARISON OF OLANZAPINE/SAMIDORPHAN VS OLANZAPINE: AN ASSESSMENT OF TREATMENT PATTERNS AND ACUTE CARE EVENTS AMONG PATIENTS WITH SCHIZOPHRENIA OR BIPOLAR I DISORDER
Mar 18, 2026, 21:38 PM -
IMPACT OF TELEMEDICINE ENCOUNTERS ON SURVIVAL OUTCOMES: A TIME-VARYING COX ANALYSIS USING EHR-DERIVED DATA
Mar 18, 2026, 21:38 PM -
REPORTING OF STUDY DETAILS IN ABSTRACTS: INFORMATIVE FOR ARTIFICIAL INTELLIGENCE (AI) OR UNDERWHELMING?
Mar 18, 2026, 21:38 PM -
BRIDGING EVIDENCE AND ACCESS: SURVEY-BASED INSIGHTS INTO HOW BIOPHARMACEUTICAL MANUFACTURERS DEVELOP AND SHARE HCEI RESOURCES
Mar 18, 2026, 21:38 PM -
THE VALUE VOCABULARY: AN ANALYSIS OF SOCIETAL TERMS IN CDA-AMC AND INESSS HEALTH TECHNOLOGY ASSESSMENT DECISION MAKING
Mar 18, 2026, 21:38 PM -
IMPACT OF PD-1 AND PD-L1 INHIBITORS ON PATIENT-REPORTED OUTCOMES IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SYSTEMATIC REVIEW OF CLINICAL TRIALS
Mar 18, 2026, 21:38 PM -
EXPLORING PHYSICIANS’ PERSPECTIVES ON BARRIERS TO ENGAGING PATIENTS WITH RARE DISEASES AND/OR THEIR CAREGIVERS IN SHARED DECISION-MAKING IN THE UNITED STATES (US): FINDINGS FROM A CROSS-SECTIONAL SURVEY
Mar 18, 2026, 21:38 PM -
DEFINING TREATMENT TOLERABILITY FROM THE PATIENT’S PERSPECTIVE: A MIXED-METHODS ANALYSIS OF THE CANCER EXPERIENCE REGISTRY
Mar 18, 2026, 21:38 PM
